B. Uner Et Al. , "Loteprednol-Loaded Nanoformulations for Corneal Delivery by Quality-by-Design Concepts: Optimization, Characterization, and Anti-inflammatory Activity.," AAPS PharmSciTech , vol.24, no.4, pp.92, 2023
Uner, B. Et Al. 2023. Loteprednol-Loaded Nanoformulations for Corneal Delivery by Quality-by-Design Concepts: Optimization, Characterization, and Anti-inflammatory Activity.. AAPS PharmSciTech , vol.24, no.4 , 92.
Uner, B., Ozdemir, S., Tas, C., Uner, M., & Ozsoy, Y., (2023). Loteprednol-Loaded Nanoformulations for Corneal Delivery by Quality-by-Design Concepts: Optimization, Characterization, and Anti-inflammatory Activity.. AAPS PharmSciTech , vol.24, no.4, 92.
Uner, Burcu Et Al. "Loteprednol-Loaded Nanoformulations for Corneal Delivery by Quality-by-Design Concepts: Optimization, Characterization, and Anti-inflammatory Activity.," AAPS PharmSciTech , vol.24, no.4, 92, 2023
Uner, Burcu Et Al. "Loteprednol-Loaded Nanoformulations for Corneal Delivery by Quality-by-Design Concepts: Optimization, Characterization, and Anti-inflammatory Activity.." AAPS PharmSciTech , vol.24, no.4, pp.92, 2023
Uner, B. Et Al. (2023) . "Loteprednol-Loaded Nanoformulations for Corneal Delivery by Quality-by-Design Concepts: Optimization, Characterization, and Anti-inflammatory Activity.." AAPS PharmSciTech , vol.24, no.4, p.92.
@article{article, author={Burcu Uner Et Al. }, title={Loteprednol-Loaded Nanoformulations for Corneal Delivery by Quality-by-Design Concepts: Optimization, Characterization, and Anti-inflammatory Activity.}, journal={AAPS PharmSciTech}, year=2023, pages={92} }